Telemedicine in cystic fibrosis

Marisa E. Desimone, Jordan Sherwood, Sarah C. Soltman, Antoinette Moran

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Cystic Fibrosis (CF) requires lifetime multidisciplinary care to manage both pulmonary and extra pulmonary manifestations. The median age of survival for people with CF is rising and the number of adults with CF is expected to increase dramatically over the coming years. People with CF have better outcomes when managed in specialty centers, however access can be limited. Telemedicine and technology-based care solutions may help to overcome barriers to availability and improve access. This review outlines the use of telehealth for CF management. Telehealth has been utilized for CF across a broad variety of indications, even prior to the COVID-19 pandemic, and in general has been well accepted by patients and providers. There are a paucity of data, however, related to health outcomes, and the healthcare utilization specific to CF and its related comorbidities. Future studies are needed to address the questions of health outcomes, cost, burdens of telehealth and barriers to implementation.

Original languageEnglish (US)
Article number100270
JournalJournal of Clinical and Translational Endocrinology
Volume26
DOIs
StatePublished - Dec 2021

Keywords

  • Cystic fibrosis
  • Cystic fibrosis related diabetes
  • Telehealth
  • Telemedicine

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Telemedicine in cystic fibrosis'. Together they form a unique fingerprint.

Cite this